Navigation Links
Tailoring Breast Cancer Treatment, from Harvard Women's Health Watch
Date:10/6/2009

Breast cancer, once thought to be a single disease, is turning out to be a collection of somewhat different disorders.

Boston, MA (Vocus) October 6, 2009 -- Breast cancer, once thought to be a single disease, is turning out to be a collection of somewhat different disorders. That knowledge is tempering the approach to treatment as experts begin using gene-based information to individualize therapies, reports the October 2009 issue of Harvard Women's Health Watch.

A key focus of breast cancer research today is identifying specific genes and protein receptors that can distinguish resistant forms of cancer from those that are easier to eradicate. In the process, it has become clear that breast cancer comes in different forms that respond to varying treatments.

The discovery of the BRCA genes in 1994 transformed approaches to prevention in women who are at high risk for breast cancer. Women carrying one of these harmful genes have options: screening via frequent mammograms and breast MRI scans, taking the drug tamoxifen to reduce the risk, or undergoing double mastectomy. Most breast cancer, though, isn't hereditary. Gene mutations are involved, but rather than being passed down from generation to generation, they crop up when errors occur in the DNA duplication process during cell division.

Advances in understanding the molecular basis of cancer have led to greater precision in identifying which tumors are more likely to recur and in targeting treatment. Harvard Women's Health Watch notes that cancer specialists are using gene-based diagnostic tests in various ways to plan more effective treatments: to determine which women are at high risk of recurrence and could benefit from chemotherapy in addition to tamoxifen; to identify women who might benefit from chemotherapy along with the drug Herceptin before surgery; and to identify women who carry certain forms of genes that help metabolize specific drugs.

Read the full-length article: "Molecular advances in early breast cancer"
Also in this issue:

 
  • Going vegetarian
  • New osteoporosis drug
  • Psychodynamic therapy for anxiety
  • Renessa for urinary incontinence
  • Knee replacement

Harvard Women's Health Watch is available from Harvard Health Publications (www.health.harvard.edu), the publishing division of Harvard Medical School, for $28 per year. Subscribe at www.health.harvard.edu/womens or by calling 877-649-9457 (toll-free).

Media: Contact Raquel Schott at Raquel_Schott@hms.harvard.edu for a complimentary copy of the newsletter, or to receive our press releases directly.

Contact:
Raquel Schott
Harvard Health Publications
617-432-5781

# # #

Read the full story at http://www.prweb.com/releases/breast_cancer/treatment/prweb3002894.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. Tailoring glioblastoma therapies: 1 size does not fit all
2. The Childrens Hospital of Philadelphia Receives Grant to Study Tailoring Pediatric Preventive Care to Individual Needs
3. An Aid to Tailoring Prostate Cancer Treatment
4. Japanese Fine Tailoring Revolutionizes Traditional Doctor Coats
5. Survival differences by race most apparent in advanced stages of breast cancer
6. MRI finds breast cancer before it becomes dangerous
7. Pathway links inflammation, angiogenesis and breast cancer
8. Drop in breast cancer incidence linked to hormone use, not mammograms
9. Breast cancer prevention practices vary across Canada
10. Eating junk food whilst pregnant and breastfeeding may lead to obese offspring
11. Acrylamide Wont Raise Breast Cancer Risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2017)... ... ... Driving Dynamics Inc., announced today it has been selected as a 2017 ... its mission to continually monitor the training marketplace for the best providers of training ... and Safety Training Companies list was based on the following criteria: , ...
(Date:9/19/2017)... ... 2017 , ... Spain’s popular line of health and wellness ... to RonnieColemanNutrition.com. , ACPG Laboratories has been in business for more than ... on the healing properties of plants, a proven science known as phytotherapy. ...
(Date:9/19/2017)... ... 2017 , ... For decades doctors, nurses, and other healthcare providers have been ... factors and calculating their cardiovascular disease (CVD) risk in the next 10 years. ... predicted today: an estimated 10-year risk prediction! , Imagine if the weatherman says there ...
(Date:9/19/2017)... , ... September 19, 2017 , ... ... the country with the Davidson Fellows Scholarship on September 27 at a reception ... in Science, Technology, Engineering, Mathematics, Literature and Music. , “I am honored to ...
(Date:9/19/2017)... ... 19, 2017 , ... Emergency nursing expertise, skill set, and ... (CEN®) certification according to a large-scale study announced today by the Board ... the Human Resources Research Organization (HumRRO) in late 2016 and early 2017, included ...
Breaking Medicine News(10 mins):
(Date:9/1/2017)... WHIPPANY, N.J. , Sept. 1, 2017  Bayer will ... at the European Society for Medical Oncology (ESMO) 2017 Congress, ... studies presented will include new preclinical and clinical data on ... from two earlier pipeline projects. ... of the best minds in cancer research at ESMO," said ...
(Date:8/29/2017)... , Aug. 29, 2017 ivWatch, LLC, the leading provider ... infiltrations, announced it has been awarded an Innovative Technology contract from ... the country. ... device to aid in the early detection of peripheral IV infiltration ... The Innovative Technology contract ...
(Date:8/28/2017)... Aug. 28, 2017 Hill-Rom Holdings, Inc. (NYSE: HRC), ... Monday, September 11, 2017, in New York ... officer, is scheduled to present at 11:05 a.m. Eastern Time. ... at http://ir.hill-rom.com/events.cfm . A recorded replay will be available ... December 10, 2017. ...
Breaking Medicine Technology: